???global.info.a_carregar???
Francisco Bischoff. Concluiu o(a) Mestrado em Mestrado em Informática Médica em 2017/12/07 pelo(a) Universidade do Porto Faculdade de Medicina. É Assistente Convidado no(a) Centro de Investigação em Tecnologias e Serviços de Saúde. Publicou 5 artigos em revistas especializadas. Atua na(s) área(s) de Ciências Médicas e da Saúde com ênfase em Biotecnologia Médica com ênfase em Biotecnologia Aplicada à Saúde. Nas suas atividades profissionais interagiu com 59 colaborador(es) em coautorias de trabalhos científicos. No seu currículo Ciência Vitae os termos mais frequentes na contextualização da produção científica, tecnológica e artístico-cultural são: Nurses knowledge in Transfusion Medicine; Transfusion Medicine in a Portuguese university hospital; Medicina básica; Basic medicine; Ciências médicas e da saúde::Medicina básica; Medical and Health sciences::Basic medicine; Adult; Clinical Protocols; Female; Hematology; Hospitals; Humans; Israel; Obstetrics; Portugal; Pregnancy; Pregnancy Complications, Hematologic; Thrombophilia; Risk Assessment; HCV; Inno-Lia; PCR; Immunoblot; Comparative Study; Israel; Portugal; Pregnancy; Risk Assessment comparative study; Thrombophilia.; Estudo Comparativo; Gravidez; Israel; Medição de Risco; Portugal; Trombofilia.; Machine Learning; Time Series; .
Read full resume ↓
Identification

Personal identification

Full name
Francisco Bischoff
Gender
Male

Citation names

  • Bischoff, Francisco

Author identifiers

Ciência ID
B413-E0A0-DE8D
ORCID iD
0000-0002-5301-8672
AuthenticusID
R-00H-DH8
Google Scholar ID
tCeA0uUAAAAJ
Researcher Id
H-8261-2016
Scopus Author Id
57189299508

Websites

Knowledge fields

  • Medical and Health Sciences - Medical Biotechnology - Health-Related Biotechnology

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
German Elementary (A2) Elementary (A2) Elementary (A2) Elementary (A2) Elementary (A2)
Spanish; Castilian Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2)
Education
Degree Classification
2019/08/01 - 2023/04/01
Ongoing
 Programa Doutoral em Ciência de Dados de Saúde (Doutoramento)
Major in Análise Inteligente de Dados da Saúde
Universidade do Porto Faculdade de Medicina, Portugal
"Detecting life-threatening patterns in Point-of-care ECG using efficient memory and processor power" (THESIS/DISSERTATION)
2015 - 2017
Concluded
 Mestrado em Informática Médica (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
"Otimização do Stock de Plaquetas através do reforço de dádivas por aférese utilizando previsão de séries temporais" (THESIS/DISSERTATION)
 19 valores
Affiliation

Teaching in Higher Education

Category
Host institution 		Employer
2017 - Current Invited Assistant (University Teacher) Centro de Investigação em Tecnologias e Serviços de Saúde, Portugal
Outputs

Publications

Conference paper
  1. Bischoff, Francisco. "Genetic Testing for Inherited Thrombophilia : 20 Years of Experience in a University and Tertiary". 2018.
    10.3390/proceedings2090527
Journal article
  1. Bischoff, Francisco. "Predicting Blood Donations in a Tertiary Care Center Using Time Series Forecasting.". Studies in health technology and informatics 258 (2019): 135-139. http://www.ncbi.nlm.nih.gov/pubmed/30942730.
    10.3233/978-1-61499-959-1-135
  2. Freixo A; Matos I; Leite A; Silva A; Bischoff F; Carvalho M; Monteiro C; et al. "Nurses knowledge in Transfusion Medicine in a Portuguese university hospital: the impact of an education.". (2016): http://europepmc.org/abstract/med/27136437.
    10.2450/2016.0185-15
  3. Salselas, A.; Pestana, I.; Bischoff, F.; Guimarães, M.; Andrade, J.A.. "Comparing the application of Hema-Obs RSS to 250 pregnancies from obstetrics/hematology consultation in centro hospitalar São João, Portugal with the application of galit sarig rss to 90 pregnancies from Rambam Health Care Campus, Israel | Comparação da aplicação da EER Hema-Obs a 250 gestações da consulta de Hematologia-Obstetrícia do centro hospitalar São João, Portugal versus EER Galit sarig a". Acta Medica Portuguesa 28 2 (2015): 189-193. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930444501&partnerID=MN8TOARS.
    10.20344/AMP.5200
  4. L. Goncalves Ricca; A. Leite; H. Gomes; C. Neves; F. Bischoff; F. Araujo. "C0247: Management of Dabigatran-Associated Severe Bleeding: The Experience of a Central Hospital". Thrombosis Research 133 (2014): S86-S87. http://dx.doi.org/10.1016/s0049-3848(14)50280-0.
    10.1016/s0049-3848(14)50280-0
Thesis / Dissertation
  1. Francisco Bischoff; Bischoff, Francisco. "Otimização do Stock de Plaquetas através do reforço de dádivas por aférese utilizando previsão de séries temporais". Master, 2017. https://repositorio-aberto.up.pt/handle/10216/110223.
    10.13140/RG.2.2.30450.56003

Other

Other output
  1. tsmp: An R Package for Time Series with Matrix Profile. 2019. Bischoff, Francisco. https://CRAN.R-project.org/package=tsmp.
    10.13140/RG.2.2.13040.30726
  2. [Comparing the Application of Hema-Obs RSS to 250 Pregnancies from Obstetrics/Hematology Consultation in Centro Hospitalar São João, Portugal with the Application of Galit Sarig RSS to 90 Pregnancies from Rambam Health Care Campus, Israel]. Pregnant women with thromboembolic diseases, previous thrombotic episodes or thrombophilia family history were supervised in a multidisciplinary Obstetrics/ Hematology consultation in Centro Hospitalar São João EPE, Porto, Portugal. For the evaluation and medication of these women, a risk stratification scale was used.. 2015. Salselas, Ana; Pestana, Inês; Bischoff, Francisco; Guimarães, Mariana; Andrade, Joaquim Aguiar. http://hdl.handle.net/10400.26/27963.
    10.20344/AMP.5200
  3. Risk Assessment Processes in Transfusion Medicine. 2014. Francisco Bischoff; Carmo Koch; Fernando Araújo. http://doi.org/10.13140/RG.2.1.1112.6169.
    10.13140/RG.2.1.1112.6169
  4. Decision on conducting HCV Immunoblot and HCV Viral Load Tests Dependent upon the Result of the Screening Tests. Testing for the presence of antibody to hepatitis C virus (anti-HCV) is recommended for initially identifying persons with HCV infection. According to the CDC guidelines it is appropriate to use a signal-to-cut-off value (S/CO) to limit the number of samples that needs supplemental testing. Moreover, the use of quantitative PCR assays for HCV RNA testing is fundamental for the assessment of chroni. 2013. Bischoff, Francisco; Koch, Maria; Araújo, Fernando; Francisco Bischoff; Maria Koch; Fernando Araújo. http://hdl.handle.net/10400.26/27964.
    10.5171/2013.332501